Influenza
Conditions
Interventions
Sponsors
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: 1. Meet the clinical diagnostic criteria for influenza in the "Influenza Diagnosis and Treatment Program (2020 Edition)"; 2. Aged 18 to 70 years; 3. Fever duration =38.5 degree; 4. Throat swab is positive for influenza virus rapid antigen test; 5. Sign the informed consent form, and the informed consent process complies with the regulations; 6. Influenza patients who have been injected with new crown vaccine patients for more than 1 month.
Exclusion criteria
Exclusion criteria: 1. Severe or critical cases of influenza, or diagnosed as pharyngeal conjunctival fever, herpetic angina, suppurative tonsillitis, etc.; 2. Those taking Xiyanping, Reduning, Tanreqing, Jinhuaqinggan, Banlangen and other traditional Chinese medicine preparations and/or immunomodulators with antiviral effects, or external use of drugs with immunomodulatory effects within 1 week before the selection; 3. Suffering from diseases that seriously affect the immune system, such as: human immunodeficiency virus (HIV) infection, or blood system, or splenectomy, organ transplantation, etc.; 4. Complications of influenza such as sinusitis, otitis media, bronchitis and pneumonia have occurred; 5. Antiviral drugs have been used within 48 hours before the visit; 6. Systemically receiving steroid therapy or other immunosuppressive therapy; 7. Have a history of epilepsy or febrile convulsions; 8. Patients with severe malnutrition, rickets and serious primary diseases of the heart, brain, liver, kidney and hematopoietic system; 9. Allergic to known components of the test drug; 10. According to the judgment of the researcher, other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as unstable living environment, inconvenient transportation, etc., are likely to cause loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune cell genus;Inflammatory factors; | — |
Countries
China
Contacts
Public ContactYe Jing
Ruijin Hospital
Outcome results
None listed